Table 3.
Preclinical DR group | Control group | t | P | |
---|---|---|---|---|
Peripapillary RNFL thickness | ||||
S (μm) | 140.97 ± 22.21 | 138.43 ± 13.20 | 0.54 | 0.59 |
T (μm) | 78.00 ± 8.30 | 86.35 ± 21.93 | −2.02 | 0.04∗ |
I (μm) | 145.29 ± 22.95 | 146.00 ± 18.67 | −0.12 | 0.90 |
N (μm) | 96.29 ± 17.30 | 96.70 ± 11.09 | −0.10 | 0.92 |
| ||||
Peripapillary vessel density | ||||
S (%) | 52.44 ± 4.29 | 54.74 ± 2.73 | −2.27 | 0.027∗ |
T (%) | 52.96 ± 3.82 | 54.35 ± 6.10 | −2.15 | 0.03∗ |
I (%) | 55.71 ± 13.63 | 55.91 ± 4.86 | −0.07 | 0.95 |
N (%) | 48.38 ± 4.21 | 49.30 ± 3.60 | −0.86 | 0.40 |
S: superior; T: temporal; I: inferior; N: nasal.